Clinical Trial

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Recruiting
View on ClinicalTrials.gov →
Summary
This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-13.
Trial Details
NCT Number NCT07033091
Lead Sponsor The Institute of Molecular and Translational Medicine, Czech Republic
Collaborators: National Institute for Cancer Research, Czech Republic
Conditions Oropharynx Cancer
Enrollment 20,000 participants
Start Date 2025-06-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-13